selpercatinib - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
RETEVMO selpercatinib 40 mg immediate release capsules AUST R: 391331Active ingredients:
selpercatinib
Dosage form:
Capsule, hard
Sponsor:
Eli Lilly Australia Pty Ltd
Phone:
0459667315
|
Deletion from market:
31 Oct 2026
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
This product will be replaced by RETEVMO selpercatinib 40 mg film-coated tablets blister pack (466116)
|
RETEVMO selpercatinib 80 mg immediate release capsules AUST R: 391330Active ingredients:
selpercatinib
Dosage form:
Capsule, hard
Sponsor:
Eli Lilly Australia Pty Ltd
Phone:
0459667315
|
Deletion from market:
31 Dec 2026
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Product is being replaced by RETEVMO selpercatinib 80 mg film-coated tablets blister pack (466128)
|